The global cardiac biomarkers market reached a value of US$ 8.2 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.
Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market report, along with forecasts for growth at the global and regional level from 2021-2026. Our report has categorized the market based on type, location of testing, and application.
Breakup by Type:
- Troponins (T and I)
- Myocardial Muscle Creatine Kinase (CK-MB)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
- Others
Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
Breakup by Location of Testing:
- Laboratory Testing
- Point of Care Testing
Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.
Breakup by Application:
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.
Regional Insights:
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Location of Testing, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered |
Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License $ 1999
Five User License $ 2499
Corporate License $ 2999 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global cardiac biomarkers industry?
- What has been the impact of COVID-19 on the global cardiac biomarkers industry?
- What is the breakup of the global cardiac biomarkers market on the basis of type?
- What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
- What is the breakup of the global cardiac biomarkers market on the basis of application?
- What are the various stages in the value chain of the global cardiac biomarkers market?
- What are the key driving factors and challenges in the global cardiac biomarkers market?
- What is the structure of the global cardiac biomarkers market and who are the key players?
- What is the degree of competition in the global cardiac biomarkers market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cardiac Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Location of Testing
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Type
6.1 Troponins (T and I)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Myocardial Muscle Creatine Kinase (CK-MB)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Myoglobin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Ischemia Modified Albumin (IMA)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Location of Testing
7.1 Laboratory Testing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Point of Care Testing
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Myocardial Infarction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Congestive Heart Failure
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Acute Coronary Syndrome
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Atherosclerosis
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Asia Pacific
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Europe
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 Global Cardiac Biomarkers Industry: SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Global Cardiac Biomarkers Industry: Value Chain Analysis
12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Global Cardiac Biomarkers Industry: Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.2 Alere Inc.
14.3.3 Beckman Coulter
14.3.4 Becton, Dickinson And Co.
14.3.5 Biomerieux
14.3.6 Bio-Rad Laboratories
14.3.7 Randox Laboratories
14.3.8 Roche Diagnostics Corporation
14.3.9 Siemens Healthcare
14.3.10 Thermo Fisher Scientific
List of Figures
Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2020
Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2020
Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2020
Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2020
Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
Figure 10: Global: Cardiac Biomarkers Industry: Porter’s Five Forces Analysis
Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2021-2026
List of Tables
Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2021-2026
Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Cardiac Biomarkers Market Structure
Table 7: Global: Cardiac Biomarkers Market: Key Players